Kidney transplantation in a patient with preformed and exclusively anti-HLA-Cw donor specific antibody

• Autor(a) principal: Santos, S.
• Data de Publicação: 2017
• Outros Autores: Castro, A., Campos, A., Pedroso, S., Dias, L., Castro-Henriques, A.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.16/2245
• topic: Donor-specific antibodies (DSA); Anti-HLA-Cw antibodies; Antibody-mediated rejection (AMR)

We report a patient who had received a first kidney transplant and had preformed DSA anti-HLA-Cw, developing AMR C4d+ soon after transplant. Classically anti-HLA-Cw are considered less immunogenic and are not considered in many organ allocation systems or immunologic risk stratification algorithms, including in Portugal. However, data from literature confirms that their presence is as deleterious as DSA anti-HLA A/B/DR/DQ. Thus we should take HLA-C typing and respective antibody identification into account in sensitized patients, in order to access risk stratification and establish the need for correct induction or desensitization therapies.